Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia.

Trial Profile

Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Amisulpride; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms AMIMIND
  • Sponsors Sanofi
  • Most Recent Events

    • 08 Dec 2010 Actual end date changed from Dec 2009 to Jan 2010 as reported by ClinicalTrials.gov.
    • 12 Feb 2010 Actual patient number (37) added as reported by ClinicalTrials.gov.
    • 12 Feb 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top